Regulatory Tech Growth Celegence combines regulatory affairs expertise with technology through CAPTIS and Copilot, signaling opportunities to upsell advanced automation, AI-assisted submissions, and literature review capabilities to life sciences firms seeking efficiency in regulatory processes.

Global Reach With offices in the U.S., U.K./Europe, and India and a global consulting team, Celegence can pursue multinational clients or expand existing customers’ regional regulatory footprints, offering consistent services across markets.

Awarded Innovation Multiple industry recognitions for CAPTIS and regulatory excellence indicate a proven value proposition; this can be leveraged to approach firms prioritizing modernization, speed, and accuracy in submissions.

Sustainability Tie‑in CDP Climate and EcoVadis sustainability ratings demonstrate environmental accountability, suggesting cross-selling opportunities to clients with ESG/regulatory reporting needs and to prospects seeking sustainable product lifecycle compliance.

PHARMA & MedTech Focus Celegence targets life sciences stakeholders from pharma, medical devices, to IVDs; there is potential to expand services such as regulatory strategy, submission management, and post-market surveillance to broader product portfolios and larger clinical pipelines.